Company Overview

Update
Founded:
2008
Headquarters:
San Carlos, CA
Funding:
$14.10M
Categories:
Biotechnology

Eiger is a biopharmaceutical company developing new antiviral agents against novel targets in the treatment of hepatitis.

Description

Update

Eiger BioPharmaceuticals is developer of treatments for strains of hepatitis.

Board Members and Advisors (1)

Update

Funding Rounds (2) - $14.10M

Update

Investors (2)

Update
  • Bb3d6fbd0e442789b59061f392f8ad0d

    InterWest Partners

    InterWest invests an average of about $7 - 15 million over the span of their involvement with each..
  • Ffd282ddd28c8fabdd3520a4e2cb89d5

    Vivo Ventures

    life-science investments

Offices/Locations (1)

Update
  • Office

    San Carlos, CA

    USA